share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A:持股变动声明(修正)-高管 Dogan Timur
美股SEC公告 ·  10/09 19:21

Moomoo AI 已提取核心信息

Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan,心脏诊断控股公司(CDIO)的首席技术官,于2024年9月6日完成了购买68,965股普通股的交易。此次交易以每股0.29美元的价格在开放市场上进行,总投资额为19,999.85美元。在这次收购之后,Dogan在公司中的直接持股增至197,310股普通股。
Timur Dogan,心脏诊断控股公司(CDIO)的首席技术官,于2024年9月6日完成了购买68,965股普通股的交易。此次交易以每股0.29美元的价格在开放市场上进行,总投资额为19,999.85美元。在这次收购之后,Dogan在公司中的直接持股增至197,310股普通股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息